|
gptkbp:instanceOf
|
gptkb:cancer
gptkb:Gynecologic_cancer
|
|
gptkbp:affects
|
gptkb:Uterus
Endometrium
|
|
gptkbp:associatedWith
|
PTEN mutation
MLH1 mutation
MSH2 mutation
P53 mutation
|
|
gptkbp:canMetastasizeTo
|
gptkb:bone
Lungs
Liver
Lymph nodes
|
|
gptkbp:commonIn
|
Postmenopausal women
|
|
gptkbp:diagnosedBy
|
Dilation and curettage
Endometrial biopsy
Transvaginal ultrasound
|
|
gptkbp:firstDescribed
|
gptkb:19th_century
|
|
gptkbp:hasScreening
|
No standard screening
|
|
gptkbp:ICD-10_code
|
gptkb:C54.1
|
|
gptkbp:incidence
|
Most common gynecologic malignancy in developed countries
|
|
gptkbp:marking
|
CA-125 (sometimes elevated)
|
|
gptkbp:predecessor
|
Endometrial hyperplasia
|
|
gptkbp:prevalence
|
More common in developed countries
|
|
gptkbp:prognosis
|
Good if detected early
|
|
gptkbp:riskFactor
|
gptkb:Lynch_syndrome
gptkb:Diabetes_mellitus
gptkb:Polycystic_ovary_syndrome
Obesity
Hypertension
Early menarche
Late menopause
Nulliparity
Tamoxifen use
Unopposed estrogen exposure
|
|
gptkbp:stageName
|
gptkb:FIGO_staging
|
|
gptkbp:subspecies
|
gptkb:Clear_cell_carcinoma
gptkb:Endometrioid_adenocarcinoma
gptkb:Serous_carcinoma
|
|
gptkbp:symptom
|
Weight loss
Abnormal uterine bleeding
Pelvic pain
Postmenopausal bleeding
|
|
gptkbp:treatment
|
gptkb:radiation_therapy
Surgery
Chemotherapy
Hysterectomy
Hormonal therapy
|
|
gptkbp:bfsParent
|
gptkb:Uterine_cancer
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Endometrial carcinoma
|